JPMorgan Chase & Co. 13D and 13G filings for REGENXBIO Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-17 11:42 am Sale | 2024-09-30 | 13G | REGENXBIO Inc. RGNX | JPMORGAN CHASE & CO JPM | 2,475,646 5.000% | -1,456,875 (-37.05%) | Filing |
| 2024-01-25 11:11 am Unchanged | 2023-12-29 | 13G | REGENXBIO Inc. RGNX | JPMORGAN CHASE & CO JPM | 3,932,521 8.900% | 0 (Unchanged) | Filing |
| 2024-01-25 11:10 am Purchase | 2023-12-29 | 13G | REGENXBIO Inc. RGNX | JPMORGAN CHASE & CO JPM | 3,932,521 8.900% | 137,836 (+3.63%) | Filing |
| 2023-01-27 12:22 pm Sale | 2022-12-30 | 13G | REGENXBIO Inc. RGNX | JPMORGAN CHASE & CO JPM | 3,794,685 8.700% | -1,210,269 (-24.18%) | Filing |
| 2022-01-18 12:59 pm Purchase | 2021-12-31 | 13G | REGENXBIO Inc. RGNX | JPMORGAN CHASE & CO JPM | 5,004,954 11.700% | 383,112 (+8.29%) | Filing |
| 2021-11-09 12:23 pm Purchase | 2021-10-29 | 13G | REGENXBIO Inc. RGNX | JPMORGAN CHASE & CO JPM | 4,621,842 10.800% | 2,089,601 (+82.52%) | Filing |
| 2021-01-15 1:15 pm Purchase | 2020-12-31 | 13G | REGENXBIO Inc. RGNX | JPMORGAN CHASE & CO JPM | 2,532,241 6.700% | 2,532,241 (New Position) | Filing |